#TCSC
LightNews LightNews
bsc-cns.bsky.social
🏅 IEEE TCSC Award for Excellence (Middle Career Researcher) 2026 para el investigador del BSC @siserte

La IEEE Computer Society le ha distinguido por sus contribuciones en la gestión dinámica de recursos en sistemas de #supercomputación.

👏 Enhorabuena, Sergio!
November 3, 2026 at 10:17 AM
knoxletter.bsky.social
TCSC Race Against Cancer
https://www.visitknoxville.com/event/tcsc-race-against-cancer/33976/

Join the free weekly Knoxville newsletter at https://knoxletter.com
November 1, 2026 at 4:09 AM
thecancersurvivorsclub.com
Why can bowel cancer be harder to treat in younger patients? Scientists studying 189 tumours found differences in cells surrounding the cancer that could help identify new treatment targets.

www.washingtonpost.com/health/2026/...

#BowelCancer #CancerResearch #TCSC
Clues emerge on why colon cancer may be harder to treat in young people
New research could offer targets for future studies and treatments.
www.washingtonpost.com
November 2, 2026 at 9:45 AM
thecancersurvivorsclub.com
A little light is making a big difference! At St. Jude, young brain tumour patient Sloane has benefited from red-light therapy to relieve painful mouth sores caused by cancer treatment, helping restore her comfort and energy.

www.stjude.org/about-st-jud...

#ChildhoodCancer #CancerCare #TCSC
Finding the light amidst brain tumor treatment
Read how St. Jude patient Sloane has gotten her shine back through the Light Therapy Program.
www.stjude.org
November 4, 2026 at 10:47 AM
thecancersurvivorsclub.com
Encouraging bladder cancer news! A trial found 75% of patients receiving enfortumab vedotin and pembrolizumab around surgery remained in remission after two years, compared with 39% receiving surgery alone.

www.hopkinsmedicine.org/news/article...

#BladderCancer #CancerResearch #TCSC
A Proven Immunotherapy Approach for Bladder Cancer Is Also Likely Cost Effective
New research led by investigators at the Brady Urological Institute found that a combination treatment for people with bladder cancer significantly improved outcomes is also likely cost-effective.
www.hopkinsmedicine.org
November 4, 2026 at 10:45 AM
thecancersurvivorsclub.com
Could a blood test help patients avoid unnecessary chemotherapy? Tumour-informed DNA testing may help doctors identify who needs more intensive treatment and who could safely receive less. An important area of ongoing research.

www.cancernetwork.com/shorts/using...

#PrecisionMedicine #Cancer #TCSC
Using Tumor-Informed MRD Testing to Escalate or De-Escalate Cancer Treatment | CancerNetwork
At the Big Ten Cancer Research Consortium (Big Ten CRC) Summit, Mark Burkard, MD, PhD, said he expects tumor-informed minimal residual disease (MRD) testing will have the biggest impact on cancer care...
www.cancernetwork.com
November 4, 2026 at 10:52 AM
thecancersurvivorsclub.com
Seven years after receiving an experimental personalised mRNA vaccine alongside surgery and chemotherapy, pancreatic cancer survivor Donna Gustafson remains cancer-free. Her remarkable story offers encouragement for cancer vaccine research.

www.wusf.org/2026-11-02/t...

#PancreaticCancer #TCSC
This woman defied lethal cancer. Can mRNA vaccines make that possible for others?
Researchers have been chasing the dream of a cancer vaccine for decades. Some recent successes with mRNA technology are garnering excitement from patients, doctors, government and investors.
www.wusf.org
November 4, 2026 at 10:50 AM
thecancersurvivorsclub.com
Major progress in lung cancer treatment! A Phase 3 trial found that adding tarlatamab to durvalumab extended median survival from 12.7 to 21.1 months in extensive-stage small cell lung cancer.

www.oncologynewscentral.com/lung-cancer/...

#LungCancer #Immunotherapy #TCSC
Tarlatamab Plus Durvalumab Improves Overall and Progression-Free Survival in Extensive-Stage Small Cell Lung Cancer
The phase 3 DeLLphi-305 trial showed tarlatamab plus durvalumab significantly improved overall and progression-free survival in extensive-stage small cell lung cancer.
www.oncologynewscentral.com
November 4, 2026 at 10:43 AM
thecancersurvivorsclub.com
Cancer spreading to the brain doesn’t mean treatment options have run out. Surgery, targeted radiation and medicines can all play a role. Mayo Clinic specialists explain how personalised treatment plans are developed.

www.thestar.com.my/lifestyle/he...

#BrainMetastases #CancerCare #TCSC
Treatments for cancers that spread to the brain 
By the time some cancers are discovered, they may have already spread to the brain.
www.thestar.com.my
November 2, 2026 at 9:46 AM
thecancersurvivorsclub.com
Encouraging lung cancer research! A Phase 3 trial is testing nivolumab, relatlimab and chemotherapy after earlier results showed improved tumour responses in certain patients with advanced non-small cell lung cancer.

www.onclive.com/view/relativ...

#LungCancer #Immunotherapy #TCSC
RELATIVITY-1093 Trial Aims to Advance Nivolumab Plus Relatlimab and Chemo in Nonsquamous NSCLC | OncLive
RELATIVITY-1093 is comparing nivolumab and relatlimab plus chemotherapy vs pembrolizumab plus chemotherapy in PD-L1–positive nonsquamous NSCLC.
www.onclive.com
November 2, 2026 at 9:45 AM
thecancersurvivorsclub.com
Sound waves could help fight brain cancer! Scientists at the University of Virginia are testing focused ultrasound and nanoparticles to deliver gene-targeting molecules against glioblastoma. Early results are encouraging.

www.sciencedaily.com/releases/202...

#BrainCancer #CancerResearch #TCSC
Scientists use sound waves to deliver a new attack on deadly brain cancer
Scientists at the University of Virginia have developed a promising new strategy to fight glioblastoma, one of the deadliest and most difficult-to-treat forms of brain cancer. Their experimental appro...
www.sciencedaily.com
November 2, 2026 at 9:43 AM
thecancersurvivorsclub.com
More than 700 people registered for the Betty Puskar Breast Cancer Walk in West Virginia, celebrating survivors and supporting patients. The event helps raise funds for education, early detection and better cancer care.

www.aol.com/articles/bet...

#BreastCancer #CancerSurvivors #TCSC
Betty Puskar Breast Cancer Walk celebrates survivors and patients - AOL
Proceeds from the event are put into education, technology, early detection, and treatments. Last year’s event raised more than $55,000, and organizers hope to raise even more money and continue to gr...
www.aol.com
November 2, 2026 at 9:47 AM
thecancersurvivorsclub.com
Promising kidney cancer results! In a 51-patient trial, alternating bevacizumab and pazopanib achieved median progression-free survival of 24.8 months and overall survival of 63.2 months.

medicalxpress.com/news/2026-10...

#KidneyCancer #CancerResearch #TCSC
Combining targeted therapies significantly boosted survival in kidney cancer study
Results of a phase 1/2 trial led by Roswell Park Comprehensive Cancer Center show that combining the targeted therapies bevacizumab (Avastin) and pazopanib (Votrient) significantly extends both progre...
medicalxpress.com
October 30, 2026 at 9:43 AM
thecancersurvivorsclub.com
Encouraging breast cancer research! A Phase 3 trial found that trastuzumab rezetecan extended median progression-free survival to 16.4 months, compared with 6.8 months on chemotherapy, in advanced HER2-low breast cancer.

www.foxnews.com/health/targe...

#BreastCancer #CancerResearch #TCSC
Targeted drug shrinks tumors in 3 out of 4 patients with advanced breast cancer
A phase 3 clinical trial published in JAMA found trastuzumab rezetecan linked to 73% lower risk of cancer progression or death versus chemotherapy.
www.foxnews.com
October 30, 2026 at 9:41 AM
thecancersurvivorsclub.com
The next generation of cancer immunotherapy is taking shape. Researchers are advancing CAR T-cell treatments and other immune therapies for blood cancers and solid tumours, opening new possibilities for patients.

www.cancernetwork.com/view/the-nex...

#Immunotherapy #CancerResearch #TCSC
The Next Frontier of Cellular Therapy in Oncology | CancerNetwork
Experts at the 2025 ICE-T Symposium reviewed CAR T-cell therapy, bispecific antibodies, and gene therapy across myeloma, lymphoma, autoimmune disease, and solid tumors, emphasizing safety and access.
www.cancernetwork.com
October 30, 2026 at 9:42 AM
thecancersurvivorsclub.com
Scientists at UCLA have found a promising way to strengthen cancer-fighting T cells. Activating the p53 protein helped engineered immune cells resist exhaustion and destroy melanoma cells more effectively in laboratory tests.

www.uclahealth.org/news/release...

#Immunotherapy #CancerResearch #TCSC
Activating cancer-fighting protein could make T-cell immunotherapies more effective, study finds
UCLA researchers identified a new strategy to make immune cells stronger and longer-lasting, a discovery that could help improve the effectiveness of immunotherapies.
www.uclahealth.org
October 30, 2026 at 9:41 AM
thecancersurvivorsclub.com
Timing could be key to better prostate cancer treatment. Researchers found hormone therapy briefly boosts immune activity in tumours, potentially creating an opportunity for immunotherapy to work more effectively.

medicalxpress.com/news/2026-10...

#ProstateCancer #Immunotherapy #TCSC
Researchers identify critical window for boosting immunotherapy response in prostate cancer
Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat prostate cancers temporarily activate the body's immune response before those ...
medicalxpress.com
October 30, 2026 at 9:44 AM
thecancersurvivorsclub.com
A major step forward for personalised cancer vaccines! A Phase 3 trial found that combining an mRNA vaccine with immunotherapy reduced the risk of melanoma returning or death by 42%.

pharmaceutical-journal.com/article/news...

#Melanoma #CancerResearch #TCSC
Personalised cancer vaccine with immunotherapy cuts risk of melanoma returning by 42%, study finds
Adding a personalised messenger RNA (mRNA) cancer vaccine to pembrolizumab — an immunotherapy drug — after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, phase III tria...
pharmaceutical-journal.com
October 30, 2026 at 9:39 AM
thecancersurvivorsclub.com
A great gesture from NBA star Brandon Miller! Inspired by his mother’s breast cancer journey, the Charlotte Hornets player provided 500 tickets for breast cancer survivors and their families to enjoy an evening together.

www.essentiallysports.com/nba-active-b...

#BreastCancer #CancerSurvivor #TCSC
Hornets Star Honors Mom’s Cancer Battle With Heartwarming Gesture Before Career-High 39-Point Night
Brandon Miller continues to celebrate mom's battle with cancer with a heartwarming gesture in career night with Hornets.
www.essentiallysports.com
October 28, 2026 at 9:55 AM
thecancersurvivorsclub.com
Encouraging melanoma breakthrough! A Phase 3 trial found a personalised mRNA cancer vaccine combined with Keytruda reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone.

www.inc.com/sage-swaby/t...

#Melanoma #CancerResearch #TCSC
This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent
A groundbreaking phase 3 clinical trial reveals that a personalized mRNA vaccine from Merck and Moderna significantly cuts the risk of melanoma returning.
www.inc.com
October 28, 2026 at 7:09 AM
thecancersurvivorsclub.com
Cancer care is about quality of life too. Carle Health has introduced portable scalp-cooling technology to help eligible chemotherapy patients reduce hair loss and preserve a sense of normality during treatment.

carle.org/newsroom/com...

#Chemotherapy #CancerSupport #TCSC
New cold cap technology available to cancer patients about to undergo chemotherapy | Carle.org
carle.org
October 28, 2026 at 7:13 AM
thecancersurvivorsclub.com
New hope for prostate cancer research! Scientists at Roswell Park have identified a window after hormone therapy when tumours may be more responsive to immunotherapy, opening the door to better treatment combinations.

www.roswellpark.org/newsroom/202...

#ProstateCancer #CancerResearch #TCSC
Roswell Park Researchers Identify Critical Window for Boosting Immunotherapy Response in Prostate Cancer
New study supports use of hormone therapy followed quickly by immunotherapy for prostate cancers, which are largely resistant to immunotherapies.
www.roswellpark.org
October 28, 2026 at 7:11 AM
thecancersurvivorsclub.com
A welcome step forward for lymphoma patients! A Cincinnati woman has become the first UC Cancer Center patient to receive CAR-T cell therapy as an outpatient, allowing her to recover in the comfort of her own home.

www.wlwt.com/article/univ...

#Lymphoma #CARTCellTherapy #TCSC
Cincinnati woman becomes first UC Cancer Center patient to get therapy as outpatient
A woman battling follicular lymphoma became the first patient at the UC Cancer Center to receive CAR-T cell therapy as an outpatient, a treatment that allowed her to recover at home.
www.wlwt.com
October 28, 2026 at 7:10 AM
thecancersurvivorsclub.com
Major progress in small-cell lung cancer! A Phase 3 trial found tarlatamab plus durvalumab extended median survival to 21.1 months, reducing the risk of death by 58% compared with durvalumab alone.

www.news-medical.net/news/2026102...

#LungCancer #Immunotherapy #TCSC
Immunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer
In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more t...
www.news-medical.net
October 28, 2026 at 7:11 AM
thecancersurvivorsclub.com
Cancer survivorship deserves celebrating! Springfield’s Rise Above Cancer Gala honoured people affected by cancer while raising funds for survivor guidance, peer support and practical resources.

www.westernmassnews.com/2026/10/25/d...

#CancerSurvivor #CancerSupport #TCSC
Downtown Springfield hosts Rise Above Cancer Gala
pringfield Mayor Domenic Sarno was in attendance for a gala Saturday honoring those living with cancer.
www.westernmassnews.com
October 26, 2026 at 9:57 AM